MTOR and autoimmune hepatitis: In summary, the original hypothesis of a lower intrahepatic Treg count in CNI-treated and a higher intrahepatic Treg count in mTOR-treated AIH patients was not confirmed in this cross-sectional study with rather heterogeneous patients.